HC Wainwright & Co. maintains TG Therapeutics $78 price target
HC Wainwright & Co. maintained its $78.00-per-share price target for TG Therapeutics,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.